TARGIN 10 mg/5 mg COMPRIMIDOS DE LIBERACION PROLONGADA

( ARTG ) TARGIN modified release tablet is indicated for the management of severe pain where:,- other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and,- the pain is opioid-responsive; and,- requires daily, continuous, long term treatment.,TARGIN modified release tablet is not indicated for use in chronic non-cancer pain other than in exceptional circumstances.,TARGIN modified release tablet is not indicated as an as-needed (PRN) analgesia,The naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.,TARGIN is indicated as a second line symptomatic treatment of patients with severe to very severe idiopathic restless legs syndrome after failure of dopaminergic therapy.